Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 17 March 2020. Marcus Vass.

Executive Summary

The forthcoming Medicines and Medical Devices (MMD) bill will allow the UK to diverge from the EU on decisions relating to digital health. Marcus Vass, head of digital health at law firm Osborne Clarke, talked to Medtech Insight about potential ramifications.

“If people’s trust is shaken, the UK would lose the chance for greater patient engagement on digital health. But if people find their sensitive data is being misused, that would throw us backwards – and a lot could go wrong.” Marcus Vass, head of digital health, Osborne Clarke

Click here for a free trial of Medtech Insight

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts